Scott Spencer

515 total citations
18 papers, 316 citations indexed

About

Scott Spencer is a scholar working on Cancer Research, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Scott Spencer has authored 18 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Scott Spencer's work include Cancer Genomics and Diagnostics (7 papers), BRCA gene mutations in cancer (4 papers) and Genetic factors in colorectal cancer (3 papers). Scott Spencer is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), BRCA gene mutations in cancer (4 papers) and Genetic factors in colorectal cancer (3 papers). Scott Spencer collaborates with scholars based in United States, United Kingdom and Switzerland. Scott Spencer's co-authors include Edwina A. Brown, Jing Hao, Marc S. Williams, Josh F. Peterson, David L. Veenstra, Gregory F. Guzauskas, Shawn Garbett, John A. Graves, Susan Snyder and Laney K. Jones and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Scott Spencer

15 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Spencer United States	7	151	124	100	87	60	18	316
Sabine Vescia Germany	5	163 1.1×	107 0.9×	71 0.7×	101 1.2×	22 0.4×	8	366
Mike Venning United Kingdom	10	38 0.3×	48 0.4×	47 0.5×	7 0.1×	131 2.2×	13	250
Chung‐Hsin Chang Taiwan	8	28 0.2×	59 0.5×	83 0.8×	7 0.1×	41 0.7×	24	219
Sandra Roe United States	10	11 0.1×	99 0.8×	110 1.1×	27 0.3×	152 2.5×	13	310
Matthew Danzig United States	13	9 0.1×	240 1.9×	187 1.9×	10 0.1×	22 0.4×	25	397
Gholamreza Bahoush Iran	10	31 0.2×	37 0.3×	26 0.3×	17 0.2×	6 0.1×	40	273
X Cuevas Spain	8	20 0.1×	28 0.2×	52 0.5×	10 0.1×	143 2.4×	20	329
Zhonglin Feng China	9	22 0.1×	63 0.5×	22 0.2×	5 0.1×	78 1.3×	24	220
Deepak Pruthi United States	11	9 0.1×	157 1.3×	93 0.9×	7 0.1×	10 0.2×	48	322
Helga Hagman Sweden	7	115 0.8×	115 0.9×	55 0.6×		30 0.5×	11	275

Countries citing papers authored by Scott Spencer

Since Specialization

Citations

This map shows the geographic impact of Scott Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Spencer more than expected).

Fields of papers citing papers by Scott Spencer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Spencer. The network helps show where Scott Spencer may publish in the future.

Co-authorship network of co-authors of Scott Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Spencer. A scholar is included among the top collaborators of Scott Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Spencer. Scott Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Spencer, Scott, et al.. (2025). Cost-Effectiveness Analysis of Comprehensive Genomic Profiling in Patients with Advanced Non–Small-Cell Lung Cancer Using Real-World Data. Journal of Molecular Diagnostics. 27(9). 850–858.

Bapat, Bela, Monika A. Izano, Molly Scannell Bryan, et al.. (2024). Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non–Small Cell Lung Cancer. JCO Precision Oncology. 8(8). e2400075–e2400075. 7 indexed citations

Byfield, Stacey DaCosta, Bela Bapat, Laura Becker, et al.. (2023). Real-world analysis of commercially insured and Medicare Advantage patients with advanced cancer and rates of molecular testing.. Journal of Clinical Oncology. 41(16_suppl). 6633–6633.

Simon, George R., Anna B. Berry, Bela Bapat, et al.. (2023). 1422P Comprehensive genomic profiling (CGP) changes management and improves survival in patients with advanced non-small cell lung cancer (aNSCLC). Annals of Oncology. 34. S812–S812. 1 indexed citations

Guzauskas, Gregory F., Shawn Garbett, Jonathan S. Schildcrout, et al.. (2023). Population Genomic Screening for Three Common Hereditary Conditions. Annals of Internal Medicine. 176(5). 585–595. 35 indexed citations

Morin, Pamela, Scott Spencer, Bela Bapat, et al.. (2023). Abstract 14482: Low Utilization of Guideline-Recommended Genetic and Pharmacogenetic Testing Among Patients With Cardiovascular Conditions in the United States (US). Circulation. 148(Suppl_1).

Jones, Laney K., Nan Chen, Dustin N. Hartzel, et al.. (2022). Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction. Circulation Genomic and Precision Medicine. 15(5). e003549–e003549. 3 indexed citations

Spencer, Scott & Stephanie M. Fullerton. (2022). Population genomic screening: Ethical considerations to guide age at implementation. Frontiers in Genetics. 13. 899648–899648. 2 indexed citations

Guzauskas, Gregory F., Shawn Garbett, Scott Spencer, et al.. (2022). Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States. Genetics in Medicine. 24(5). 1017–1026. 13 indexed citations

10.

Spencer, Scott, Laney K. Jones, Gregory F. Guzauskas, et al.. (2022). Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States. Journal of clinical lipidology. 16(5). 667–675. 15 indexed citations

11.

Spencer, Scott, Gregory F. Guzauskas, Federico Felizzi, et al.. (2021). Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma. Journal of Managed Care & Specialty Pharmacy. 27(5). 615–624. 1 indexed citations

12.

Lee, Woojung, et al.. (2021). Improvements in access to cancer clinical trials facilitated by comprehensive genomic profiling in non-small cell lung cancer.. Journal of Clinical Oncology. 39(28_suppl). 59–59. 1 indexed citations

13.

Guzauskas, Gregory F., Shawn Garbett, Scott Spencer, et al.. (2020). Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States. JAMA Network Open. 3(10). e2022874–e2022874. 49 indexed citations

14.

Hart, Ragan & Scott Spencer. (2019). Consideration for Employer-Based and Geographic Attributes Included in Value Assessment Methods of Next-Generation Sequencing Tests. Journal of Managed Care & Specialty Pharmacy. 25(8). 936–940. 2 indexed citations

15.

Afessa, Bekele, et al.. (2001). Association of pulmonary artery catheter use with in-hospital mortality. Critical Care Medicine. 29(6). 1145–1148. 22 indexed citations

16.

Robert, Francisco, David Raben, & Scott Spencer. (1999). UFT/oral calcium folinate plus radiation in pancreatic cancer.. PubMed. 13(7 Suppl 3). 127–8. 3 indexed citations

17.

Spencer, Scott, et al.. (1990). Transitional-Cell Carcinoma in Acquired Cystic Disease of the Kidney in a Patient on CAPD. Nephrology Dialysis Transplantation. 5(6). 464–465. 2 indexed citations

18.

Spencer, Scott, et al.. (1988). Subclavian Stenosis: A Major Complication of Subclavian Dialysis Catheters. Nephrology Dialysis Transplantation. 3(4). 423–425. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact